Multiple Sclerosis and Related DisordersVolume 39, April 2020, 102073CommentaryThe COVID-19 pandemic and the use of MS disease-modifying therapiesAuthor links open overlay panelGavin Giovannoni a, Chris Hawkes a, Jeannette Lechner-Scott b, Michael Levy c, Emmanuelle Waubant d, Julian Gold a eShow moreShareCitehttps://doi.org/10.1016/j.msard.2020.102073Get rights and contentPrevious article in issueNext article in issueRecommended articlesCited by (0)View Abstract© 2020 Elsevier B.V. All rights reserved.